Skip to content
PICO Portalanswers from OpenAlex

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

PaperCitations, authors & open-access status

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer have?

PICO Portalcitation count

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer has 847 citations in the OpenAlex counts PICO Portal stores.

When was The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer published?

PICO Portalyear

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer has 2014 year in the PICO Portal index.

What is the open-access status of The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer?

PICO Portaloa status

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer has bronze oa status in the PICO Portal index.

What is the DOI of The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer?

PICO Portaldoi

The DOI for The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer is on the source record.

What is the PMID of The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer?

PICO Portalpmid

The PMID for The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer is on the source record.

What is the OpenAlex record for The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer?

PICO Portalopenalex

The OpenAlex for The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial